MedTech News
Erbe Launches FiAPC® plus to Elevate Argon Plasma Coagulation Precision
Next-Generation Technology Enhances Control, Safety, and Efficiency in Flexible Endoscopic Procedures
Mercury Medical Partners with Flat Medical to Launch EpiFaith® Smart Syringe in the U.S.
Innovative Partnership Aims to Enhance Epidural Safety with Real-Time Pressure Sensing Technology for Improved Patient Outcomes
VitalFlow™ ECMO System Earns CE Mark, Strengthening Medtronic’s Cardiac Portfolio
The CE Mark approval of the VitalFlow™ ECMO System marks a significant advancement in extracorporeal life support, delivering enhanced precision and control for managing critically ill cardiac and respiratory patients.
Terumo Neuro Unveils New SOFIA™ 88 Catheter Data Demonstrating Strong Performance Compared to Other Super-Bore Catheters
NASHVILLE, Tenn., July 14, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today unveiled new real-world U.S. physician preference data for the SOFIA™ 88 Neurovascular Support Catheter at the 2025 Society of NeuroInterventional Surgery (SNIS) Annual Meeting. The data—presented publicly for the first time —demonstrates strong performance compared to other super-bore catheters in key performance metrics such as trackability, atraumatic design and overall physician-rated experience.
Optical microscopy combined with AI could enable new avenues in precision medicine
“Precision medicine” has become increasingly popular in the last decade as an avenue for cancer therapy, where treatment strategies are tailored to a specific patient based on the unique characteristics of their disease and their personal background.
New imaging technique monitors protein changes in cancer cells without dyes
Researchers from Helmholtz Munich and the Technical University of Munich have developed a novel method to track cancer treatment responses in individual cells—without the need for dyes or labels.
New blood test predicts multiple sclerosis risk years before symptoms appear
A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of certainty years before the onset of symptoms.
Skin swabs could detect Parkinson’s disease up to seven years before symptoms appear
A new study has revealed promising progress in developing a non-invasive sampling method to detect early signs of Parkinson’s disease—up to seven years before motor symptoms appear—by analyzing the chemical makeup of skin.